Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients

Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients

Positive serum antinuclear antibody (ANA) is not infrequent in chronic hepatitis C virus (HCV)-infected patients. This prospective study evaluated the impact of ANA on the response to and safety of peginterferon/ribavirin combination therapy for chronic hepatitis C patients in clinical practice. We...

Full description

Bibliographic Details
Main Authors: Ming-Yen Hsieh, Chia-Yen Dai, Li-Po Lee, Jee-Fu Huang, Wan-Long Chuang, Nai-Jen Hou, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang, Ming-Lung Yu
Format: Article
Language:English
Published: Wiley 2012-02-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Antinuclear antibody (ANA)
Hepatitis C virus
Peginterferon
Ribavirin
Sustained virological response (SVR)
Online Access:http://www.sciencedirect.com/science/article/pii/S1607551X11002543

Internet

http://www.sciencedirect.com/science/article/pii/S1607551X11002543

Similar Items